Answers are grounded in this paper and cite their sources.
BACKGROUND: The association between HLA class II antigens and the production of red cell autoantibodies was investigated in this study. STUDY DESIGN AND METHODS: Thirty-one individuals with a positive direct antiglobulin test (DAT) and 85. DAT-negative controls (cadaveric organ donors) were typed using a DNA-based method for class II HLA typing, that is, the polymerase chain reaction with sequence-specific primers. Amplified HLA alleles corresponding to the serologic specificities DR 1-18 and DQ 1-9 were identified. RESULTS: Analysis of DR and DQ frequencies showed that HLA-DQ6 was less frequent in DAT-positive individuals (19% vs. 53% in the control population), with a p value of 0.0014 and a corrected p value of 0.059, and relative risk of 0.23 (95% Cl = 0.09-0.58). The frequency of HLA-DQ6 was higher in asymptomatic DAT-positive blood donors (n = 8, 38% DQ6 positive, p = 0.48) than in DAT-positive hospital and clinic patients (n = 23, 13% DQ6 positive, corrected p value = 0.030, relative risk = 0.13, 95% Cl = 0.04-0.41), 96 percent of whom had evidence of clinical hemolysis. CONCLUSION: This study demonstrates that HLA-DQ6 may have a negative association with a positive DAT result in patients with evidence for hemolysis, and may be a resistance antigen for clinically relevant red cell autoantibodies.
No takes yet. Share an insight, caveat, or question.
Wang‐Rodriguez et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: